Short answer
Pennant Group, Inc. (PNTG) filed an 8-K current report with the SEC on November 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Q3 2026 financial results for quarter ended September 30, 2026.
Pennant Group, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q3 2026 financial results for quarter ended September 30, 2026
- Press release provides Pennant Group’s detailed operating and financial results
- Investors should review Exhibit 99.1 for revenue, earnings, guidance and performance drivers
Item 7.01 · Regulation FD Disclosure
- Updated investor presentation signals new or refreshed messaging for upcoming investor meetings
- Materials available at investor.pennantgroup.com for investor review
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $302.3M, up 32.0%, with net income $9.6M up 58.5% and diluted EPS $0.26
- Adjusted diluted EPS $0.35 versus $0.30, while adjusted EBITDA rose 42.4% to $24.7M
- Home health and hospice revenue $239.8M, up 38.2%, driven by admissions growth and hospice census expansion
- Same-store home health admissions increased 8.0% and hospice census 13.0%, indicating organic momentum beyond acquisitions
- Senior living revenue rose 12.6%, but occupancy declined 250 basis points to 78.4%, a key execution risk despite pricing growth
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Pennant Group, Inc. 8-K filings
Get the next PNTG 8-K as it lands
Follow PNTG for push alerts, or ask the research agent what this filing means.